NEW YORK — U.S. regulators are planning a public hearing to collect more information on CBD in cosmetics, foods and other products as the cannabis compound spreads in popularity.
CBD comes from marijuana or hemp plants but does not cause a high. People have been drawn to the extract because of its supposed calming effects.
The Food and Drug Administration says the May 31 meeting will discuss the science, safety and sale of cannabis compounds like CBD. In December, the agency said CBD is not approved for use in food, drinks and dietary supplements, but noted that could change. It also said any products that make drug or treatment claims also need to be approved by the FDA.
The FDA has approved a pharmaceutical version of CBD to treat rare seizure disorders.
